Morning Market Losers
February 17, 2015 at 09:53 AM EST
Celsus Therapeutics Plc (NASDAQ: CLTX) shares dropped 81.36% to $1.15 on failed Phase 2 MRX-6 cream trial. Vascular Biogenics ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.